Distribution of health-related social surplus in pharmaceuticals an estimation of consumer and producer surplus in the management of high blood lipids and COPD

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The European journal of health economics
Weitere Verfasser:	Camejo, Rodrigo Refoios (BerichterstatterIn), McGrath, Clare (BerichterstatterIn), Miraldo, Marisa (BerichterstatterIn), Rutten, F. F. H. (BerichterstatterIn)
Format:	UnknownFormat
Sprache:	eng
Veröffentlicht:	2014
Schlagworte:	Consumer surplus > Producer surplus > Dynamic efficiency > Research and development > Pharmaceutical innovation > Pharmaceutical policy > Aufsatz in Zeitschrift
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Titel	Jahr	Band
Patient-reported outcomes : opportunities and challenges in Central Europe	2019	Volume 20, supplement 1 (June 2019)
Biological and biosimilar therapies in inflammatory conditions : challenges for the Central and Eastern European countries	2013	15.2014, Suppl. 1
The development of new research methods for the valuation of EQ-5D-5L	2013	14.2013, Suppl. 1
Special issue on economic evaluation	2010	11.2010,1
Health economics without frontiers : 6th European Conference on Health Economics July 6-9, 2006 - Budapest, Hungary ; abstracts, oral presentations, poster presentations	2006	7.2006, Suppl. 1
The cost of multiple sclerosis in Europe : costs and quality of life in multiple sclerosis in Europe: method of assessment and analysis	2006	7.2006, Suppl. 2
Health outcomes in schizophrenia : = Gesundheitsökonomische Aspekte bei der Behandlung schizophrener Patienten	2002	3.2002,Suppl. 2